Compass Pathways PLC
NASDAQ:CMPS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Compass Pathways PLC
NASDAQ:CMPS
|
UK |
|
Mineralbrunnen Ueberkingen-Teinach GmbH & Co KgaA
F:MUT
|
DE |
Intrinsic Value
The intrinsic value of Compass Pathways PLC (CMPS) under the Base Case is 3.39 USD per share.
Compared with the current market price of 11.12 USD, the stock appears
Overvalued by 70% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Compass Pathways Does
Compass Pathways is a biotechnology company focused on developing psilocybin-based treatments for mental health conditions, especially difficult-to-treat depression. It is trying to turn a psychedelic compound into a controlled prescription medicine that can be used in a medical setting with therapist support.
- Headquarters
- United Kingdom UK
- Employees
- 156
- IPO date
- Sep 18, 2020
Earnings Waterfall
Compass Pathways PLC
The intrinsic value for Compass Pathways PLC (CMPS) under the Base Case is 3.39 USD.
Compared with the current market price of 11.12 USD, the stock appears Overvalued by 70% .